| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.59▲ | 2.60▼ | 2.60▼ | 2.86▼ | 3.19▼ |
| MA10 | 2.60▼ | 2.61▼ | 2.63▼ | 3.14▼ | 3.56▼ |
| MA20 | 2.60▼ | 2.63▼ | 2.75▼ | 3.44▼ | 3.84▼ |
| MA50 | 2.60▼ | 2.84▼ | 3.04▼ | 3.75▼ | 4.94▼ |
| MA100 | 2.63▼ | 3.06▼ | 3.33▼ | 4.01▼ | 4.44▼ |
| MA200 | 2.74▼ | 3.37▼ | 3.61▼ | 4.83▼ | 3.51▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.011▲ | 0.004▲ | -0.094▼ | -0.110▼ |
| RSI | 46.227▼ | 31.950▼ | 25.019▼ | 17.828▼ | 26.174▼ |
| STOCH | 19.167▼ | 26.006 | 17.205▼ | 4.929▼ | 12.078▼ |
| WILL %R | -66.667 | -79.310▼ | -93.478▼ | -97.719▼ | -98.442▼ |
| CCI | -102.247▼ | -63.374 | -76.013 | -161.216▼ | -223.523▼ |
|
Tuesday, May 19, 2026 05:00 PM
Oppenheimer analyst Leland Gershell maintains Protara Therapeutics (NASDAQ:TARA) with a Outperform and raises the price target from $25 to $28. JP Morgan analyst Brian Cheng maintains Protara ...
|
|
Tuesday, February 24, 2026 07:23 AM
Protara Therapeutics (NASDAQ:TARA) on February 23, 2026, announced updated interim data from its ongoing Phase 2 ADVANCED-2 trial evaluating intravesical TARA-002 in patients with high-risk non-muscle ...
|
|
Thursday, December 04, 2025 04:30 AM
Protara Therapeutics maintains strong momentum with TARA-002, showing durable, high complete response rates in NMIBC and promising efficacy in lymphatic malformations. TARA-002’s 6-month complete ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/10/26 | 2.70 | 2.71 | 2.565 | 2.595 | 846,481 |
| 02/10/26 | 2.81 | 2.95 | 2.62 | 2.70 | 1,909,316 |
| 01/10/26 | 3.06 | 3.10 | 2.745 | 2.76 | 4,999,036 |
| 30/09/26 | 3.23 | 3.30 | 2.98 | 3.05 | 8,597,603 |
| 29/09/26 | 3.33 | 3.345 | 3.21 | 3.21 | 388,119 |
| 28/09/26 | 3.27 | 3.386 | 3.19 | 3.25 | 431,133 |
| 25/09/26 | 3.35 | 3.44 | 3.23 | 3.28 | 552,913 |
| 24/09/26 | 3.54 | 3.55 | 3.315 | 3.35 | 661,838 |
| 23/09/26 | 3.69 | 3.75 | 3.44 | 3.54 | 882,844 |
| 22/09/26 | 3.55 | 3.88 | 3.55 | 3.68 | 2,893,235 |
|
|
||||
|
|
||||
|
|